Abstract Current cost-based approach in measuring health care output does not allow decomposition of health care expenditure into price and output components. In this paper we propose an episode-based direction measurement method which closely resembles the concept of output in the system of national accounts. Using data from the Canadian Institute for Health Information, we calculate a quality unadjusted output index of the Canadian hospital sector for the periods 1996-2005. The result shows that total output increases at an average annual growth rate of 1.49%. We expect that with the quality adjustment the actual rate is higher. This is in contrast with the long-held assumption that health care productivity growth is zero. Our results provide key information on the ongoing health care policy debate.
Introduction
Health care expenditures have gained increasing attention by policy makers in Canada and other industrialized countries because of their rising trends, both in dollar values and as percentages of national incomes. In Canada, provincial governments, which are responsible for the funding of the single-payer systems, have implemented various cost-control policy to "bend the cost curve" in health care. Depending on institutional and economic factors in each province, they have employed policy tools such as market incentive, input cost control, efficiency improvement, hard budget cap, etc. (Marchildon and Di Matteo 2015) . Discussions, however, focus mainly on total expenditure of the health care section. Total expenditure is an important statistic simply because in most countries, where a large part of health care services is provided or funded by the public sector, it has the largest share in government budgets. There is some concern that rising costs could put some strain in public finance. Table 1 shows for the G7 countries in 2012 the total health care expenditures as a percentage of national income, percentages of health care spending that was publicly funded, expenditures per person expressed in U.S. dollars, and for the period 1990 to 2012 the average annual change in expenditure per person. The publicly and privately funded components of health care expenditures in 2012 are depicted in Fig. 1 . An interesting observation is that the public expenditures in all seven countries are within a narrow range of 7-9%. The U.S. stands out for its high total expenditure due to an even larger private sector. A thorough policy analysis, national or international, requires the breakdown of expenditure changes into price changes and output (quantity) changes. An increase in expenditure may arise from a price change, which can be caused by higher compensation for the med-ical staffs or more expensive drugs and equipment. On the other hand, it can be caused by increased demand for health care services due to technological or demographic changes. The distinction between these two components of expenditure changes can be the key information in the process of finding policy solutions (Gerdtham and Jönsson 2000) . In many "cost-driver" analyses, total expenditures are usually deflated by a general price index such as the CPI or the GDP deflator (see, example, CIHI 2011). The resulting "real expenditure", however, is not a true quantity index for the health care sector. It is instead the opportunity cost of the health care system compared with the rest of the economy.
Economic statisticians, however, face serious challenges in price and output measurement in the health care sector. First, for the majority of citizens in industrialized countries, health care services are not direct out-of-pocket expenses but are covered by private or public insurance. Moreover, insurance policies vary in coverage, deductibles, and other details. Market prices are therefore not directly observable. Second, as in other products in the service sector, quantities of health care output are not well-defined. As a consequence direct measurement of output is not a straight-forward exercise. Third, due to rapid technological changes, new treatment methods and new diagnoses frequently introduce new goods and services. Biases result if the scope and product mix of the services are not updated fast enough. Finally, for the same diseases methods of treatment improve over time. These create biases in the price or the output index if the quality changes are not reflected in the indices.
Due to its unique market structure among industrialized countries, research in the U.S. has focused mainly on the price measurement of health care services. Its statistical agencies publish periodically a consumer price index (CPI) and a producer price index (PPI) for the health care sector. In Canada, a larger proportion of health care expenditure is publicly financed. Therefore direct measurement of output seems to be more appropriate. There is an important difference between price measurement and direct output measurement. A price index can be calculated by taking samples of prices for the same good or service. Direct output measurement, however, has to be exhaustive, and therefore more data intensive. Some countries such as the U.K. have implemented direct output measurement in a number of government services, including the health care sector.
In this paper we examine the theoretical and practical aspects of health care output measurement in Canada. Currently only total expenditure is reported in the Canadian system of national accounts (SNA). Since total input costs are taken as total output, it is not possible to calculate the total factor productivity of the sector. It is our hope that this research project contributes to the debate in health care output measurement in Canada and eventually leads to a practical solution.
Basic problems
We start with the basic index number problem in price and quantity aggregations. Consider a total of N goods and services with prices p t i and quantities q t i in period t, i = 1, . . . , N . A bilateral price index P is a ratio of the general price levels between a comparison period (t = 1) and a base period (t = 0), and similarly a bilateral quantity index Q is a ratio of output levels between the two periods. The product of P and Q, by definition, is equal to the ratio of the total expenditures between the two periods:
For marketed goods and services with observable prices and quantity, price data are collected by an appropriate sampling method for each good and services. A price index is calculated using a selected index formula. For example, the Laspeyres price index is defined as
where
is the expenditure share of good i in period 0. Once P is calculated, Q is implicitly implied by the identity in (1). In the U.S. for example, efforts are focused on getting the price index in health care. The real output is then obtained by deflating the nominal output (expenditure) with P. In Canada this procedure also is used to calculate real outputs in out-of-pocket expenses such as prescription drugs and services of optometrists and dentists. In services provided or funded by the government where market price data are unavailable or do not exist, it is necessary to measure the quantity directly. As mentioned above there are a number of technical challenges facing statisticians. In the health care sector the units of measurement that define quantities of services are ambiguous. We shall examine this problem in detail below. If new treatment methods are available in period 1 but not in period 0, then a structural break occurs in the index formula. In price measurement this will create an upward bias in the price index if the basket of goods and services is not updated frequently. In direct output measurement, however, it is not clear how the problem can be resolved in a satisfactory manner. The biggest challenge is how to incorporate quality change into the quantity index. For industries where price measurement is possible, statisticians have employed subjective adjustment, matched model, and hedonic analysis to allow for quality changes. The last method uses regression analysis to control for changes in characteristics or attributes of a product. 1 Failure to incorporate quality improvement will result in a downward bias of the quantity index.
On the input side of the health care system, suppose there are M input factors such as doctors, nurses, a cancer treatment drug, MRI, etc., with prices (or wages) w t i and quantities x t i in period t, where i = 1, . . . , M. The total cost in period t is therefore M i=1 w t i x t i , where t = 0, 1. The cost ratio if the two periods again can be decomposed into an input price index P * and an input quantity index Q * :
A productivity index P r of the health care sector from period 0 to period 1 can be defined as the ratio of the output quantity index Q in (1) and the input quantity index Q * in (3):
Since total cost in health care is the same as total expenditure, we have
in both periods t = 0, 1. The four indices on the left-hand side of (1) and (3), however, have different trends. Policy makers should be aware that different cost control policies affect different components in P, Q, P * , and Q * . For example, a salary or fee restriction imposed on nurses or doctors affect mainly P * , while a hard budget cap reduces the overall quantity of services Q. The overall performance of the system should be measured by the productivity index P r in (4). Meaningful policy debates, therefore rely on the accurate measurement of the price and quantity indices in the health care sector.
Measuring quantities
The production of goods and services can be roughly divided into four stages, namely, inputs, activities, products, and outcomes. of treatment, quality of care, etc. An episode is defined as a hospital stay or a day surgery visit for a given condition during a specific year. For example, a patient who was admitted and discharged more than one time within a year for the same condition or procedure would be counted more than once. 4. Outcomes-health status of patients adjusted for environmental and socio-economic factors.
Measuring costs
Most countries, including Canada, traditionally measure the total costs of inputs as total expenditures in publicly provided services such as hospital care. Since price information at the consumer level is generally unavailable, changes in total expenditure are treated as pure price changes. In other words, Q is assumed to be 1 in every period, forcing the price index P equal to the expenditure ratio. Sharpe et al. (2007) report that the average annual real output growth of the hospital sector in Canada is 1.02% from 1984 to 2003. From the theoretical standpoint, the cost-based approach can be justified by considering the government as a provider of health care services with cost function C(w, q) where w is the input price vector. Assuming zero economic profit, the output prices are the elements of the vector of marginal costs, p = ∇ q C(w, q). If we further assume that technology exhibits constant return to scale, then q ·∇ q C(w, q) = C(w, q) and so cost will be the "correct" value for government outputs (Yu 2010) . Marginal costs, however, are not easily observable. Additional difficulties arise in the definitions of quantity.
Measuring activities
Starting from 1998, the U.K. has switched from an input-based measurement to an activitybased one. In the health care sector there are 16 activity series such as inpatient and day cases, outpatient and community health treatments, general practitioner services, dental services, etc. 2 In any series, activities such as surgeries performed or number of consultations are aggregated using a Laspeyres quantity index:
where a t i is the number of activities i in period t and p 0 i is its average cost in period 0. These "cost-weight activity indices" was implemented until 2004, when the series were expanded and the definitions of activities were more refined.
From the patients' perspectives, the number or level of activities such as number of diagnostic tests conducted, surgeries performed, or length of hospital stay is not the main concern. It is, instead, whether or not an acute disease or injury can be cured as quick as possible, or a chronic illness can be under control with minimum impacts on their quality of life. Therefore, if a cancerous tumour can be removed with less amount of hospital stay and fewer number of intrusive surgical procedures or chemotherapy treatments, it should be considered as a quality improvement. Although there is a decrease in activities, output measures should be adjusted upward. Therefore activities can be an inappropriate measure as a proxy for output.
Measuring cases
There are an increasing number of economists suggesting that health care measurement, particularly for hospital services, should move towards an episode based approach. 3 The idea is close to the concept of a product in a market economy, which is the object of measurement in the system of national accounts. Hospital services, for example, can be classified according to a well-defined system of taxonomy such as the International Classification of Diseases (ICD) published by the World Health Organization (WHO). 4 In the latest version, ICD-10, each type of disease is coded by an alphabet with a two digit number. For example, J60 represents anthracosilicosis, a lung disease suffered mostly by coal mine workers. The Canadian version is called ICD-10-CA. The number of cases in each type of disease can be compared and an elementary quantity index calculated. These indices should in principle be adjusted for severity and quality of care because more lung cancer treatments do not necessarily mean better productivity. Aggregation can be achieved by weighing the elementary indices with their relative costs.
Measuring strictly outcomes
There has been a large volume of research on cost effectiveness (CE) in health care services. 5 One of the objectives of these analyses is to study the technical efficiency of two or more treatment methods for a particular disease. For example, the cost-effectiveness ratio between two treatment methods A and B for the same disease is defined as
where p A , p B , e A , and e B are respectively their costs and measures of effectiveness. A relatively low ratio means that treatment A is more cost-effective than B. Note that the costs of the treatments should include both direct cost and indirect costs, which may be time of treatments, income loss, etc. The effectiveness measure can be simple mortality rates, success rate of curing, an appropriate physiologic measure such as blood pressure, hormone level, etc., or a combination of several desirable characteristics. Cost-effectiveness ratios can also be used to study allocative efficiency across diseases. The effectiveness e in this case must be a general outcome measure of the well-being of the patients. Commonly used measures are usually based on improvement in quality and quantity of life due to the medical intervention. For example, the quality-adjusted life years (QALY) of a patient can be defined as the present value of the weighted sum of all future life years. For a patient with age A,
where w i is a weight between 0 and 1, π i is the probability of the patient being alive at age i, and δ is a time discount factor. The weight factor w i is equal to 1 when the patient is in perfect health and 0 if dead. 6 The interpretation of δ is ambiguous. It incorporates both the intertemporal time preference structure of the patient and his/her attitude towards risk and uncertainty. This ambiguity, however, is common in cost-benefit analysis. 7 If QALY is multiplied by the dollar value of a statistical life year, the cost-effectiveness ratio in (5) becomes dimensionless, which is useful in cross-disease analysis and international comparison of the same treatments. Another utility-based outcome measure directly models the patients' preferences on health status under risk. Suppose a patient has a von Neumann-Morgenstein utility function U (Q, t) on health status Q and life year t. Then the health-year equivalent, H is implicitly defined as
Here Q H is a perfect health status or profile for H year and Q T is the patient's actual health profile for T years. That is, the patient is indifferent between living H years under perfect health and T years under the condition Q T . Conceptually health-year equivalent is similar to the certainty equivalent in expected utility theory. The conversion of any health profile is transformed to a standard measure so that health years can be aggregated across patients and diseases. If the weights w i truly present a patient's preference structure, the QALY in Eq. (6) should in theory the same as the health-year equivalent H in Eq. (7). Cost-effectiveness analysis is a powerful tool in studying technical and allocative efficiencies. But can it be used as an outcome measure for the purpose of national accounts? In principle, the change in health status of all citizens due to medical intervention can be used as a proxy for the real output of the health care sector. 8 The question raises several theoretical and practical issues.
First, cost-effectiveness analysis is mainly used as a tool to compare different treatments at a particular time. Analysts are more concerned with the ranking of the CE ratios than the values per se. In output measurement for the purpose of national account, however, the accuracy of the numbers is important (Triplett 1999) .
Second, health outcomes are determined by the health care services and other factors such as genetic inherence, socio-economic factors, knowledge and lifestyle of the patients and the public health environments. 9 In cost-effectiveness analysis patients under different treatments are assumed to have the same average background. For national account purposes, however, these factors have to be adjusted for. The analytical tools are not yet available.
Third, the Canadian SNA publishes national income or Gross Domestic Product (GDP) on a quarterly basis. Measuring the life expectancy of our citizens is already a large undertaking. Life tables are available on a yearly basis from Statistics Canada. Measuring the health-adjusted life expectancy of the whole country is a formidable task with the existing information technology and resources. This indicator does not generally change much over a short period of time and it would not be meaningful to measure it every 3 months or so.
Fourth, the overall effects of some treatments, particularly those due to newly developed technology, may be observable only after a long time. Technically speaking the QALY defined in (6) are expected values instead of actual values. Therefore the GDP will be subject to future revisions, which is not a desirable feature for users.
Finally, the purpose of the national accounts is to measure values of economic transactions, not the effects or outcomes of consumption. For example, satellite TV service companies often offer packages that include hundreds of channels. How many channels the consumers actually watch and how much they enjoy the programs is not the target of measurement from the SNA perspective. It is well-known that smoking reduces health outcomes. Therefore in principle in the outcome approach consumption of tobacco should have a negative entry in the health account. Moreover, if an approach based only on outcomes is used, a dollar value should be attributed to QALYs in order to be able to enter the indicator in the National Accounts; which again is a touchy concept.
For the above reasons the quality-adjusted episode-based approach is conceptually closer to the real output of marketed product than the approach based only on outcomes.
Quality change
Traditionally, economic statisticians adjust prices of marketed goods with replacement, subjective price adjustment, and matched technique. For example, if a car model in the comparison period includes an air conditioner as a standard feature, the price should be adjusted downward using the extra cost of adding the air conditioner in the base period. For multivariate quality changes, statisticians use hedonic analysis to untangle the price changes. The technique requires large amount of price and quantity data together with their characteristics for each product variety. Nevertheless, the overall price changes can be inferred from a manageable data set. In direct quantity measurement, however, quality data must be collected for every product variety. Also, due to the absence of price information, other techniques have to be used to adjust the quantity data for quality changes.
A widely used tool in cost-benefit analysis is the use of contingent valuation method (CVM) for non-marketed goods such as environmental amenity. The procedure involves interviews, questionnaires, or experimental techniques to ask the respondents directly about their willingness-to-pay (WTP) for the goods, or infer the values indirectly from the experiments. CVM has become acceptable after some studies show that the results yield WTP similar to results using other direct approaches such as the hedonic method and the travelling cost method. CVM can in principle be used for evaluating quality changes in direct output measurement. In the case of health care services provided by private insurance coverage, Pauly (1999) suggests that the price of a quality change of a particular treatment is the difference in premiums charged by the insurance company for including the new treatment in the package. This price difference provides a lower bound estimate for the consumers' WTP for the quality change. For publicly funded system with universal coverage, however, he recommends using a general effectiveness measure such as QALY since inclu-sion of more costly new treatment methods is a collective choice which involves altruistic externalities.
A quantity index for Canada
Except for some services such as drugs, vision, eye and dental care, the Canadian health care system is publicly funded by general tax revenue and supplementary health premiums charged by some provinces or territories to households. The premiums, if charged, are far below their market values and are independent of the citizens' health status or age. Since coverage is universal for hospitals and physicians, the system avoids the high transaction costs of adverse selection and statistical discrimination. Woolhandler et al. (2003) report that the overall administration cost of the health care system in the U.S. is 31.0% of the total health expenditure, compared with 16.7% in Canada. 10 Due to the funding nature of the system, market prices or marginal costs for insurance coverage or for individual services are not available. In this section we develop a preliminary episode-based output index which uses case mix groups (CMG) and the day procedure groups (DPG) as a proxy for quantity. The CMG as it is known today was introduced in Canada in 1990 and has undergone several improvements. 11
A cost weighted output index
As discussed in Sect. 3.1 we assume that the providers such as hospitals as non-profit organization, the social optimal prices should be the marginal costs. For example, let C(w, q) be the cost function of a hospital where w is the input price vector and q is the output quantity vector. Then the output price vector is p = ∇ q C(w, q). Furthermore, if we assume that technology exhibits constant returns to scale, then the total cost is given by C(w, q) = p · q = ∇ y C(w, q) · q. In addition, we assume that producers minimize cost given the existing technology, with a separable cost function for each output. In particular, let the cost function for output i be 1) is the unit cost function of product i. The output price is assumed to be the marginal cost in each period, that is,
With these assumptions the total cost in period t is the sum of the costs of individual outputs, that is,
Diewert (2008) defines the cost weighted output quantity index as
Here we compare two total cost functions with outputs q 1 and q 0 , while keeping the input price vector w and technology (expressed in C t ) the same. The Laspeyres output quantity index uses period 0 input prices and technology in the above definition, giving
The second choice uses period 1 input prices and technology and give the Paasche output quantity index as
The third choice is the Fisher output quantity index, which is the geometric mean of the Laspeyres and Paasche indices:
To allow for quality changes, the output quantity q t i is augmented by a quality adjustment factor e t i . For example, a Laspeyres-type quantity index with quality adjustment is defined as 12 To measure the real output of inpatient and outpatient services provided by hospital, number of episodes for each major clinical category (MCC) or case mix group (CMG) can be used for q. Alternatively, number of episodes for each ICD-10-CA clinical chapter can be used for q. These quantities are available from the Discharge Abstract Database (DAD), the Hospital Morbidity Database (HMDB) and the National Ambulatory Care Reporting System (NACRS). If MCC or CMG are used, resource intensity weights (RIW) developed by the Canadian Institute for Health Information (CIHI) can be used as cost share s i for each MCC or CMG. If ICD-10-CA clinical chapter is used, average cost per stay can be used as cost share s i for each chapter. 13 Average costs per stay by clinical chapter and for selected medical conditions in [2004] [2005] for Canada are also available (CIHI 2008a). They can be estimated by province and for different years.
12 Diewert (2008) measures productivity changes using a productivity index Q/Q * where Q is an output quantity index and Q * is an input quantity index. Productivity changes are reflected in the change in the production function over time in producing the same products. Here e reflects the quality changes in the products themselves. 13 RIW values or average cost per stay used to set the weights are derived from data that do not include fee-for-service payments to physicians or out-of-pocket expenses.
Practical considerations
The index in (8) calculates the overall output of the health care sector. In practice the overall index is likely to be aggregated from second-level subindices, which can be based on the major clinical categories. For example, in ICD-10 Group I, diseases of the circulatory system is further divided into ten subgroups such as acute rheumatic fever (I02), pulmonary heart disease and diseases of pulmonary circulation (I28), cerebrovascular diseases (I69), etc. At the subgroup levels, each disease can sometimes be treated with several treatment methods. Quality changes often involve improvement of existing methods or invention of new methods. It is at this level that new goods enter and substitutions occur.
The quality enhancing adjustment factors can be applied at two stages: at the product stage and at the outcome stage. At the product stage, adjustment can be made for unsuccessful or iatrogenic cases such as unplanned re-admissions. In this case, q t i would be defined as the number of successful episodes i in period t. A successful episode would be defined as an episode for which there was no re-admission for the same condition after a certain period of time which could vary depending of the condition.
At the outcome stage, the adjustment factor e t i can be a disease-or treatment-specific outcome measure such as a physiologic measure, a psychometric scale, or a utility-based measure such as health-adjusted life expectancy (HALE), or an index of different measures.
Generally, e t i should be a ratio scale with a true zero point so that it can be multiplied and divided (McDowell 2006, p. 715) . The measure taken for each category should be based on the expert knowledge in that particular field. 14 Whether QALYs are sensitive enough for this remains to be determined.
The HALE family includes measures such as QALY and DALE (disability-adjusted life expectancy). QALYs can be computed for specific diseases by subtracting the conditiondeleted mortality rates from the overall mortality rates in the life table and by removing people with specific conditions from the survey used to generate the quality weights (Manuel et al., 2003) . They are based on the Health Utilities Index (HUI) and were produced by Statistics Canada for the provinces and Canada for 2001 (CANSIM Table 102 -0121). QALYs are preferred to DALYs because they are multi-dimentional and, in the Canadian context, they can be readily available. In order to compute individual quality-adjusted output, QALYs need to be available on a periodic basis for each MCC or ICD-10-CA clinical chapter, which is currently not the case. However, the CIHI-Statistics Canada initiative to advance Canada's capacity to understand health outcomes is a step in the right direction. A joint report on the capacity of data holdings to support health outcomes research will be developed. The report will address data gaps and will look broadly at major diseases and a range of interventions of interest (CIHI 2008b) . Currently, aggregate DALE measures are available for 1996 (Statistics Canada 2002) and aggregate HALE measures are available for 2001. However, the same measure should be used at the base period and the end period because these DALE and HALE are not based on the same health-related quality of life (Gold et al. 2002) . Moreover, these aggregate measures need to be updated.
The determination of the quality adjustment factors is a large undertaking which involves the collaboration of medical experts, health economists, and economic statisticians in each category of diseases. CIHI and Statistics Canada have recently established the Health Outcomes Conceptual Framework "to guide data development and analysis for health outcomes at a population level" (CIHI 2008b, p. xi) . The process is similar to what Shapiro and Wilcox (1996) call "house-to-house combat" of measuring quality change in a price index. Moreover, these indicators do not change much in the short-run. For these reasons, it could be more practical to consider a satellite account for the health care sector (OECD 2000) . A satellite account is a parallel account that provides estimates alongside the national account estimates of the health care sector. Satellite accounts make the use of complementary and alternative concepts so that there is extended coverage of costs and benefits that are of particular social concern. However, satellite account estimates do not need to be produced as often as national account estimates.
Since the individual quality adjustment factors e i will not be available in the near future, a possible compromise is to adjust for quality changes at the aggregate level. For example, Formula (8) can be modified as
where e t is the average overall quality adjustment measure in period t adjusted for environmental and socio-economic factors and the aggregate quantity of treatment. Researchers have generally agreed on the dimensions of measuring quality in health care (Arah et al. 2006) . WHO (2002) provides an extensive discussion of summary measures of population health. The use of aggregate quality adjustment is not uncommon in direct output measurement. For example, in the U.K. National Accounts a quality adjustment factor of 0.25% per year is applied to the output of schools in the education sector. 15 In passing we should take the caution that a general measure of community health outcome such as expected life-years is not appropriate as the overall adjustment factor e t in (9). Generally, changes in these type of factors encompass the following three components:
1. Environmental factors such as air and water quality, smoking habits, exercises, consumption of fast food and alcohol, etc. 2. Changes in quantities of health care received (building more hospitals, more treatments of diabetes, more heart surgeries, etc.) 3. Improvement in the quality of treatments (more effective drugs, improved imaging technology, improved surgery techniques, etc.)
Our output index described in the next section is a measure of component 2 above. The quality adjustment factor e t , if available, would take care of component 3. Expected lifeyears includes all three components. Therefore if we use it as e t in Eq. (6), we would commit the error of double counting component 2 and also the error of including component 1, which has nothing to do with health care output.
Episode-based indices
In this section we provide an empirical example using CIHI's data on hospital inpatient and day surgery services in Canada from 1996 to 2005. The nine-year period is split into two sub-periods: 1996-2000 where data were submitted in ICD-9 format and 2003-2005 where data is submitted in ICD-10-CA format. In 2001 and 2002, data were submitted to the DAD in ICD-9 format for some jurisdictions and in ICD-10-CA for others. So, this implementation of ICD-10-CA was staggered across Canada. To avoid the structural break, indices for these 2 years are not calculated. Moreover, all jurisdictions were included except Quebec, Manitoba and Alberta. 16 We take the assumption that there are no quality changes in all CMG in consecutive periods. In future work, this assumption will be relaxed to explicitly account for quality changes. With the no-quality change assumption, the index becomes
which is a commonly used Laspeyres quantity index. Similarly, the Paasche-type quantity index Q P can be calculated using the comparison period average cost p 1 i in (8) or (9). The Fisher quantity index is simply the geometric mean of Q L and Q P , which is currently used by Statistics Canada in the SNA. Table 2 shows the three chained quantity indices for the 1996-2000 and 2003-2005 periods in Canada. From the trends we observe that the Paasche being the upper bound and the Laspeyres being the lower bound of the theoretical quantity index (Diewert 1993, p. 189) . The Fisher index is the geometric mean of the two and therefore is a close approximation of the true quantity index. In column 4, the Fisher index Q F between 1996 and 2000 is 1.037 and between 2003 and 2005 Q F = 1.054. Even when we assume that there are no changes between 2000 and 2003, the overall quantity index between 1996 and 2005 is 1.093. This translates into an average annual growth rate (AAGR) of 1.49% for the 6 year period for which the index is calculated. This index provides a lower bound for the hospital output in Canada since it is unadjusted for quality improvement. In other words, from 1996 to 2005, Canada's total hospital output on average has increased at least by 1.49% per year. Population of the included provinces grow at the rate of 1.09% from 1996 to 2005. Therefore the average annual growth rate for the hospital sector is 1.49 − 1.09 = 0.40% per person. With quality adjustment we expect the growth rates to be higher. This information is a piece of the puzzle in the whole picture that provides insight into the ongoing policy debate on the health care system. Figure 2 plots the three chained indices from 1996 to 2005 by assuming that the rates of growth for the missing years are the same as the average of the others. Note that Sharpe et al. (2007) report that the average annual real output growth of the hospital sector in Canada is 1.02% from 1984 to 2003 (no adjustment for quality). Unadjusted output growth for the period 1995 to 2004 was 3.2% per year in the British NHS (ONS 2006) . Column 3 in Table 3 reports the total hospital expenditure in Canada of the same years, with the chained expenditure index in Column 4. 17 Using Eq. (1) an implicit price index or deflator is calculated and reported in Column 5, assuming Alberta, Manitoba, New Brunswick, and Quebec have the same trends as in the rest of the country. The price level from 1996 to 1999 are relatively stable, but increases significantly in 2000 and from 2003 to 2005. The average annual price change for the 6 year period is 3.06%. Keep in mind that this price index is unadjusted for quality changes. With the adjustment we expect the price changes to be lower. The contribution of an accurate measurement of the price and quantity indices to policy debate can be demonstrated using Table 3 . From 1999 to 2000, for example, the expenditure index jumps from 1.064 to 1.154, which is equivalent to an increase of 8.5%. The quantity index, however, drops from 1.039 to 1.037, which is a decrease of 0.3% in total output. This means that the overall implicit price had increased more than the expenditure while output growth is negative. In this case, policy makers should look at the factors contributing to price (or wage) increase.
Canadian indices

Provincial indices
On the national level, the overall output index grows at the average annual rate of 1.49%. Results at the provincial level, however, show a variety of growth rates. Table 4 lists the chained Fisher quantity indices for the provinces for the years in which data are available. The provinces which experienced high average growth are PEI, Ontario, and Saskatchewan, at 2.15, 1.90, and 2.52% per year respectively. Newfoundland and the Territories on the other hand suffer a decline in overall output. More interesting details are revealed by looking at the trends. Figure 3 depicts the trends of the indices reported in Table 4 . Again for provinces in which the [2003] [2004] [2005] indices are available, the values for the missing years are assumed to be the same as the average rates in those provinces. Most of the output growth in Prince Edward Island, for example, happens in 1998, after which the trend become steady. Spending on hospital services depends on a number of factors such as demography and government funding (Di Matteo and Di Matteo 1998) . Average population growths of each province are listed on the second last row of Table 4 for the years in which the indices are calculated. The last row reports the output growth rates minus the population growth rates, which is the output growth rates per person. For example, adjusted for population change, output per person in fact increases at the rate of 0.77% per year in Newfoundland. These provincial indices provide valuable information for policy analyses.
Conclusion
In this paper we have reviewed and discussed the theoretical and practical problems of measuring the real output of the health care system in Canada. The decomposition of total expenditure change into a price change and a quantity change is important in policy analysis and international comparison of output and productivity. Techniques in cost-effectiveness analysis can be modified in principle to measure quantity via only the outcome of the health care sector. This approach, however, has some conceptual issues that are not compatible with the purpose of the system of national accounts. Moreover, frequent measurement of health outcome for the whole country is impracticable. It has been shown that an episode-based quality adjusted index is conceptually closer to the Canadian SNA concept. Because this approach requires also measurement of health outcomes, its implementation is very data intensive. Data on quantities are available from the Discharge Abstract Database (DAD) or the Hospital Morbidity Database (HMDB) and the National Ambulatory Care Reporting System (NACRS). Data on cost shares are available from CIHI's resource intensity weights or can be made available from special studies in the case of average cost per stay or unit cost.
However, comprehensive data on health outcomes or quality of care is not readily available on a periodical basis. Using the available data, we calculate the episode-based quantity index for the periods 1996-2000 and 2003-2005 . Our results show that the real output unadjusted for quality change increases at an average annual rate of 1.49%. The index needs to be adjusted for quality changes using measure such as QALY. Details of future quality adjustment for each major clinical category requires the inputs from a team of medical experts, health economists, and economic statisticians. Unavailablility of appropriate data for the quality adjustment suggests that steps should be taken to make these data available in the future. The CIHI and Statistics Canada intitiative to advance Canada's capacity to understand health outcomes is a step in the right direction.
